Peptide Therapy:
SS-31 (Elamipretide): A Peptide That Targets the Inner Mitochondrial Membrane
There is a reason some patients do everything right — optimize their hormones, clean up their diet, commit to exercise — and still feel like they are running on a depleted battery. The answer is often not what you are doing. It is the state of the cellular machinery doing the work.
SS-31 works differently from stimulants: it acts on mitochondria rather than on the nervous system.
While MOTS-c acts as a metabolic messenger — restoring how your mitochondria signal and communicate — SS-31 goes deeper. It binds cardiolipin in the inner mitochondrial membrane and, in laboratory and animal studies, protects the structure of the membrane folds where energy is made.1
At YoungerMeMD, SS-31 is offered as part of our EnergizeMe Suite — physician-supervised, pharmacy-verified, and tailored to your biology.
SS-31 — also known by its clinical name elamipretide — is a synthetic tetrapeptide engineered specifically to target the inner mitochondrial membrane.21 Unlike stimulants that mask fatigue or hormone therapies that work through receptor signaling, SS-31 travels directly into your cells and concentrates inside the mitochondria themselves, where it binds to a structural molecule called cardiolipin.32
Cardiolipin is found almost exclusively in the inner mitochondrial membrane.4 It acts as a structural anchor for the respiratory complexes — the protein machinery responsible for generating ATP, the energy currency of every cell in your body.5 Changes in cardiolipin structure and content have been associated with mitochondrial dysfunction in aging and in several diseases.6
SS-31 binds cardiolipin. In laboratory and animal studies, this stabilizes mitochondrial membrane structure, reduces oxidative stress and improves ATP production.71
SS-31 is not a stimulant or a hormone.
The clearest way to understand SS-31's role is to think about your mitochondria the way you'd think about a computer system.
In animal studies, it acts as a metabolic signal that regulates fuel use and insulin sensitivity.8 It improves how the system runs.
It targets the physical membrane where energy production happens. Whether this changes how people feel has not yet been established outside specific diseases. However, anecdotally, positive patient outcomes are noted.
For patients already on MOTS-c, adding SS-31 addresses the layer beneath the signal — the structural foundation that determines how much the signal can actually accomplish. For new patients, Dr. Varano will evaluate which entry point fits your current picture.
Mitochondria are present in virtually every cell of the body, but the benefits of SS-31 in people have been studied mainly in specific mitochondrial and heart diseases. Patients in the EnergizeMe SS-31 program at YoungerMeMD frequently report:
I finally have energy that doesn’t run out by noon — and I’m not chasing it with coffee.
Deeper, More Sustained Energy — In a small randomized trial in older adults with poorly functioning muscle mitochondria, a single dose of elamipretide briefly increased muscle mitochondrial ATP production, but it did not improve muscle fatigue resistance. Effects on everyday energy levels have not yet been studied.9
I was exhausted in a way that sleep couldn’t fix. That’s finally changing.
Reduction in Deep, Unrefreshing Fatigue — Elamipretide has been tested for fatigue in people with primary mitochondrial myopathy, a genetic mitochondrial disease: a small 4-week trial reported less fatigue, but the larger 24-week phase 3 trial found no improvement in fatigue or walking distance compared with placebo. It has not yet been studied as a treatment for general fatigue.1011
My workouts stopped plateauing. I’m recovering faster and actually getting results again.
Improved Exercise Performance and Recovery — Muscle cells are among the most mitochondria-dense tissue in the body. In aged mice, SS-31 improved muscle mitochondrial function, fatigue resistance and endurance. Improvements in exercise performance or recovery have not yet been demonstrated in healthy people. Anecdotally, though, patients do report positive outcomes.1213
The brain fog lifted. I didn’t realize how much cognitive ground I’d lost until I got it back.
Sharper Mental Clarity and Focus — The brain is one of the most metabolically demanding organs in the body and one of the most mitochondria-dense. The effects of SS-31 on focus or mental clarity have not yet been studied in human clinical trials. However, anecdotally, positive patient outcomes are noted.
I feel like my body is actually rebuilding — not just maintaining.
I’ve optimized everything else. This was the missing layer.
Enhanced Response to Other Therapies — Whether SS-31 changes the response to hormones, other peptides or nutrients has not yet been studied.
SS-31 is not a first-line therapy for general fatigue. It is a targeted intervention for patients who are doing many things right — and who recognize that something deeper may be limiting their results.
You may be a strong candidate for the EnergizeMe SS-31 protocol if:
Your hormones are optimized, but you still feel flat or fatigued
You sleep adequately but wake unrestored, with fatigue that rest doesn’t fix
Your workout performance has plateaued despite consistent training and nutrition
You’re already on MOTS-c and want to address the deeper structural layer
You experience brain fog or mental fatigue that isn’t explained by other factors
You’re proactively investing in longevity and want to protect mitochondrial function over time
You’ve optimized lifestyle, diet, and supplementation — and still feel like you’re running at 70%
Your YoungerMeMD provider will review your full clinical picture before recommending this protocol. Not every patient needs SS-31 as a starting point, and our team will help you identify the right entry into the EnergizeMe program.
Every SS-31 protocol at YoungerMeMD is physician-supervised by Dr. Varano from evaluation through each cycle. This is not a product you order online. It is a medical protocol — tailored, monitored, and adjusted based on your response.
Your journey begins with a comprehensive evaluation by Dr. Varano — reviewing your symptoms, health history, labs, and cellular health markers. This assessment looks for possible causes of your symptoms, establishes a baseline, and helps decide whether SS-31, MOTS-c or neither is appropriate.
$279/month
Membership provides the continuous oversight that makes peptide therapy work. Dr. Varano and the team monitor your protocol across cycles, adjust as needed, and stay accessible throughout. No surprise fees, no gaps in coverage.
Three ways to add SS-31 to your protocol — depending on where you’re starting from.
Add it at any time during your MOTS-c journey; your provider will go over how it fits and what it costs at your assessment.
Why the Stack Works
MOTS-c and SS-31 act on mitochondria in different ways: MOTS-c is a signaling peptide, while SS-31 binds cardiolipin in the inner mitochondrial membrane. The combination has not yet been studied in clinical trials, and an added benefit has not yet been established.
SS-31 (elamipretide) is a mitochondria-targeted peptide that binds cardiolipin, a key structural molecule in the inner mitochondrial membrane.716 Unlike stimulants, SS-31 acts directly on mitochondria, but it has not yet been shown to treat everyday fatigue in people without mitochondrial disease. Anecdotally, though, patients do report positive outcomes.
MOTS-c is a mitochondrial-encoded signaling peptide that regulates insulin sensitivity and metabolic homeostasis in animal studies. SS-31 is a cardiolipin-binding peptide that targets the inner mitochondrial membrane.81 Think of MOTS-c as the software update and SS-31 as the hardware repair. Some patients benefit from one; many benefit from both. Dr. Varano will evaluate your current picture and recommend the right entry point.
SS-31 is administered as a 16-day subcutaneous injection protocol. It is available for up to 3 cycles per year. It can be taken as a standalone program, added to the MOTS-c standard plan ($225/month), or included automatically in every cycle under the Premium EnergizeMe Stack ($275/month). SS-31 pricing on its own is discussed at your assessment. All options are supervised by Dr. Varano.
A subcutaneous injection is a small, self-administered injection just beneath the skin, similar to how insulin is delivered. Most patients find it straightforward after the first use. Our team provides complete instruction and support before your first dose to ensure you are comfortable with the process.
Response timelines vary based on the individual, degree of mitochondrial dysfunction, and whether SS-31 is part of a broader protocol. There are no clinical trial data on the 16-day, 3-cycles-per-year schedule. In a study in older adults, the effect of a single elamipretide dose on muscle energy production was no longer detectable 7 days later.9
In most cases, yes. Combinations of SS-31 with BHRT, MOTS-c or other peptides have not yet been studied in clinical trials. Your provider will review your current program and confirm the right combination for your specific situation.
Elamipretide has been studied in clinical trials in people with specific conditions, such as primary mitochondrial myopathy and Barth syndrome, where it was generally well tolerated and injection site reactions were the most common side effect. Its long-term safety in healthy adults, and the safety of compounded versions, have not been studied.1117 There are no human data on elamipretide use in pregnancy or while breastfeeding, so SS-31 should not be used in either situation.16 Dr. Varano will review your full medical history, current medications, and health status before recommending this protocol.
Elamipretide received FDA accelerated approval in September 2025, as Forzinity, only to improve muscle strength in patients with Barth syndrome weighing at least 30 kg. Compounded SS-31 used for other purposes is not an FDA-approved product, and its effectiveness for energy, performance or anti-aging has not yet been established.1718 At YoungerMeMD, all peptide therapies are prescribed under medical supervision and sourced exclusively from regulated compounding facilities — never from unregulated online suppliers.
Yes. At YoungerMeMD, peptide therapy is medicine — and we treat it that way. A prescription ensures you are an appropriate candidate, that the therapy is correctly dosed for your protocol, and that you receive a sterile, potency-verified product from a regulated compounding pharmacy. Membership is required for all peptide programs.
At YoungerMeMD, peptide therapy is treated as real medicine — because it is. Every SS-31 prescription is sourced exclusively from fully vetted, state-licensed 503A compounding pharmacies that meet the highest standards for sterility, potency, and consistency.
The internet is flooded with SS-31 and elamipretide products labeled ‘for research purposes only.’ These are not appropriate for human use. The risks associated with unregulated peptide sources — unknown potency, contamination, improper handling — are real and significant. When you receive an SS-31 prescription from YoungerMeMD, you receive a product that is sterile, accurately dosed, and compounded to pharmaceutical standards under full clinician oversight.
By partnering only with top-tier compounding pharmacies, we protect the integrity of your peptide journey and ensure SS-31 is prescribed with clinical oversight and prepared to consistent quality standards.
Structure is the foundation of everything.
SS-31 acts on the inner mitochondrial membrane rather than on signaling pathways. It has not yet been shown to improve the results of other therapies.
Most patients who add SS-31 are already working on other areas of their health. Here is how it fits:
SS-31 has not yet been shown to make other therapies more effective.
EnergizeMe Suite — Complete the Protocol
SS-31 repairs the structural foundation of cellular energy production. These programs work alongside it — each targeting a different layer of performance, recovery, and longevity optimization.
MOTS-c and SS-31 are the two pillars of complete mitochondrial optimization at YoungerMeMD. MOTS-c is a mitochondrial-encoded signaling peptide that, in mice, prevented insulin resistance and diet-induced obesity. SS-31 binds cardiolipin in the inner mitochondrial membrane. The combination has not yet been studied in clinical trials.8
Two Ways to Stack MOTS-c + SS-31
Option A — Start MOTS-c, Add SS-31 As You Like
$225 /month MOTS-c
Add the SS-31 cycle whenever you're ready — pricing is discussed at your assessment. You decide the timing.
Option B — Premium EnergizeMe Stack Most Popular
$275 /month
3 months MOTS-c + 16-day SS-31 built into Month 4 every cycle. Fully managed by Dr. Varano — nothing to coordinate.
Hormones signal through cells that require mitochondrial energy to respond. Whether SS-31 changes the results of hormone therapy has not yet been studied. Fatigue that persists despite hormone treatment has many possible causes and warrants a full medical evaluation.
Growth hormone secretagogues like CJC-1295 + Ipamorelin and Sermorelin stimulate the pituitary to produce GH — supporting muscle building, body composition, and recovery. Whether SS-31 changes the response to these peptides has not yet been studied. SS-31 addresses the cellular infrastructure; Peak Performance addresses the hormonal signal that drives adaptation.
Tissue repair is one of the most metabolically expensive things the body does. BPC-157 and the Wolverine Stack target repair at the tissue level — but those processes depend on the cellular energy available to carry them out. Whether combining SS-31 with healing peptides improves recovery from injury or surgery has not yet been studied.
You have optimized your life. Now it is time to optimize your biology.
SS-31 is not about pushing harder. It is about repairing the structure that makes everything else possible — so that your energy, your performance, and your resilience reflect the investment you have already made in your health.
SS-31 is prescribed and monitored from our Conshohocken clinic, in Montgomery County just outside Philadelphia. Bloodwork is drawn locally and visits are available in person or by telehealth across Pennsylvania.
YoungerMeMD · 125 East Elm Street, Suite 201, Conshohocken, PA 19428 · (215) 892-1230
Fill up the form below to get started
No provocation agent required. A urine test that checks for toxic metals standard labs do not routinely test for.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.
Estimates nutrient-related markers from DNA methylation with an at-home finger-prick kit. Not a diagnostic test; flagged results are confirmed with standard blood work.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
We use cookies from Google Analytics, Google Ads and Contentsquare to measure visits and ads. Nothing loads unless you click Accept. Cookie policy
